Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
about
Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae FamiliesComputational methods in drug discoveryFragment-based modelling of single stranded RNA bound to RNA recognition motif containing proteins.Unique helicase determinants in the essential conjugative TraI factor from Salmonella enterica serovar Typhimurium plasmid pCU1.In silico fragment-based drug design using a PASS approach.Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replicationDiscovering new medicines targeting helicases: challenges and recent progress.Binding Site Identification and Flexible Docking of Single Stranded RNA to Proteins Using a Fragment-Based Approach.A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase.Fragment informatics and computational fragment-based drug design: an overview and update.De novo design: balancing novelty and confined chemical space.Designing the molecular future.Protein signatures using electrostatic molecular surfaces in harmonic space.Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target.Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.HCV genetics and genotypes dictate future antiviral strategies.
P2860
Q26700087-0EF93BDE-1B09-47D6-9F46-82A372A6AC29Q26997089-0034DA25-42D5-4595-BBA2-F46A99306865Q30387519-56A502CA-3C9F-4B87-A947-A52AD4A847D3Q34056764-22461884-3FE3-45BB-8AEF-17AEC14EF6CCQ34174920-C2809C9F-9D61-4839-92B6-5FD5A17F7D68Q34361091-13EDF34C-C873-4A8C-98B5-B5E6AC8393C5Q35592783-430009FA-C6C8-4CB5-B0E2-1F1DDA501DA2Q35905559-E9F797C7-551E-4281-9DA0-CC0F4DEC5C36Q36822284-36C6130E-3823-49BB-B93D-00D847039EDEQ37995087-CAFA7C26-15B6-4151-9BDC-8A1AF2DB7B97Q38029143-EC5F6045-42D7-4A48-B97D-84F05BCF56C7Q39681302-8165921F-4034-444D-8892-7B32A9E26818Q40230250-3D1A9FD2-4CED-43C5-9B31-DEE1986A46F8Q40243959-7A1E6729-9DE7-49D5-860D-D80EA4D6183CQ41931663-50D4E0A2-89D8-4BC9-B4F4-267E36B5ACFFQ47547339-AF448A68-F232-4679-8675-7AD1E8EB6AB8
P2860
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@ast
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@en
type
label
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@ast
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@en
prefLabel
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@ast
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@en
P2093
P50
P1476
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
@en
P2093
Anna-Claire Cummins
Antonio Coluccia
Sonia Biondaro
P304
P356
10.1016/J.BMCL.2009.04.074
P407
P577
2009-04-22T00:00:00Z